Molecular Templates Garners $8,500,000 Series C Funding

  • Feed Type
  • Date
    10/8/2013
  • Company Name
    Molecular Templates
  • Mailing Address
    111 W. Cooperative Way Georgetown, TX 78626
  • Company Description
    Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers.
  • Website
    http://www.moleculartemplates.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,500,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    This round of financing will allow us to develop our technology around antibody-drug conjugates, siRNA delivery, and enzyme replacement therapy while continuing to advance our lead compound, MT-3724.
  • M&A Terms
  • Venture Investor
    Excel Venture Management
  • Venture Investor
    Excel Venture Management
  • Venture Investor
    Sante Ventures

By posting a comment, you agree to our terms and conditions.